reference/22283116

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22283116

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	103
issn	0002-8703
pageRange	94-103
publicationName	American Heart Journal
startingPage	94
bibliographicCitation	Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Yusuf S, Siegbahn A, Wallentin L. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Am Heart J. 2017 Aug;190():94–103. doi: 10.1016/j.ahj.2017.06.001. PMID: 28760218.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dacc5b7b431ed648bf7ed5359b1f5e2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9afd58f8f928e6e66bab149d1edcb73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f8cae243db7d69d614a5e5c12507102 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9969-3921 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22a732584f7956adfea241c3610e3bbf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf365e4ba685f12df64c487559057d36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8beb197e529aafd22326b72f102fd1f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4776-5601 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_162224ded4f74ef0664e01968ca52a19 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7420-743X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cda1a5555356569965216160c3dd1c9f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34e907618bde6c9ad6a62c36f0f20877
date	201708
identifier	https://pubmed.ncbi.nlm.nih.gov/28760218 https://doi.org/10.1016/j.ahj.2017.06.001
isPartOf	https://portal.issn.org/resource/ISSN/0002-8703 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/398
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
discusses	http://id.nlm.nih.gov/mesh/M0291263 http://id.nlm.nih.gov/mesh/M0001380 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0282507
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006470Q000139 http://id.nlm.nih.gov/mesh/D020521Q000517 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D001281Q000150 http://id.nlm.nih.gov/mesh/D000925Q000009 http://id.nlm.nih.gov/mesh/D055436Q000097
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D015996Q000639 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D013548Q000453 http://id.nlm.nih.gov/mesh/D020521Q000209 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006470Q000097 http://id.nlm.nih.gov/mesh/D020521Q000453 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D002170Q000453 http://id.nlm.nih.gov/mesh/D001281Q000188 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006470Q000453 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D015415Q000097 http://id.nlm.nih.gov/mesh/D000925Q000008 http://id.nlm.nih.gov/mesh/D015994 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D014481Q000453 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D004305
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d

Showing number of triples: 1 to 66 of 66.